N-(5-Fluoro-2-methylphenyl)-4-methylbenzenesulfonamide, 97%, 250mg

Hybridisation vial Non-coated, Height, 300 mm, 70 mm, 1 Piece

6-Fluoroindoline, 95.0%, 250mg

3-Borono-4-ethoxybenzoic acid, 97%, 250mg

Sebacic acid monomethyl ester, 97%, 100g

2,4,6-Tris-(4-bromo-phenyl)-[1,3,5]triazine, 95.0%, 10g

(S)-4-Phenyl-2-(2-((S)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole, 98%, 1g

1-Methyl-4-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)piperazine, 95%, 100mg

4-Bromo-4'-hydroxybiphenyl>99.0%(GC)5g

2-Chloro-6-(trifluoromethyl)nicotinamide, 97.0%, 25g

2,4,6-Triphenylpyrylium tetrafluoroborate, 95.0%, 5g

Methyl 3,5-Dibromophenylacetate, 98.0%, 250mg

2-Bromo-3-methyl-1,5-naphthyridine, 95.0%, 250mg